Language
English
Publication Date
5-1-2026
Journal
JACC: Heart Failure
DOI
10.1016/j.jchf.2025.102780
PMID
41329105
Keywords
GLP-1 receptor agonist, cardiovascular outcomes, cardiovascular risk, glucagon receptor agonist, obesity, overweight
Published Open-Access
yes
Recommended Citation
Platz, Elke; Kaplan, Lee M; le Roux, Carel W; et al., "Survodutide for the Treatment of Obesity: Baseline Characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial" (2026). Faculty, Staff and Students Publications. 6641.
https://digitalcommons.library.tmc.edu/baylor_docs/6641